Coronary Archives - iVascular

Coronary Press Release

Exceptional Long-Term Outcomes of iVascular Angiolite Drug-Eluting Stent in Real-Life Clinical Practice

Barcelona— iVascular is pleased…

adminFebruary 20, 2025

All Clinical Trials Coronary

iVascular announces first enrollment in new ANGIODAPT trial, an RCT of abbreviated DAPT post-stent implantation in all-comers

First patient enrolled in…

iVascularJanuary 18, 2024

All Clinical Trials Coronary

RANGO Registry new 3-year follow up outcomes

After the positive pre-clinical…

iVascularJuly 26, 2022

Coronary Coronary and peripheral news

iVascular, Angiolite DES offers new long lengths of 44 and 49mm.

Barcelona, February 9th, 2021.…

adminFebruary 9, 2021

All Coronary Coronary and peripheral news

iVascular, Angiolite 6.00mm maximum overexpansion capacity.

We are pleased to…

adminJanuary 13, 2021

Clinical Trials Coronary

Angiolite is now reimbursed in Belgium.

iVascular is pleased to…

adminSeptember 3, 2020

All Clinical Trials Congresses Coronary Coronary and peripheral news Partnership Peripheral

iVascular- MERLION Trial 6-month outcomes have been presented at VIVA 2020 Late breaking trial session.

Barcelona, June 26th, 2020.…

adminJune 26, 2020

All Clinical Trials Coronary Peripheral

iVascular COVID 19 letter

The COVID 19 pandemic…

adminJune 15, 2020

All Clinical Trials Coronary Coronary and peripheral news

iVascular – essential pro, new coronary drug coated balloon

Barcelona, June 15th, 2020.…

adminJune 15, 2020

All Coronary

ANGIOLITE trial 2 years outcomes have been published at EuroIntervention

Barcelona, 22 of January,2020.…

adminJanuary 22, 2020

Coronary

Exceptional Long-Term Outcomes of iVascular Angiolite Drug-Eluting Stent in Real-Life Clinical Practice

iVascular announces first enrollment in new ANGIODAPT trial, an RCT of abbreviated DAPT post-stent implantation in all-comers

RANGO Registry new 3-year follow up outcomes

iVascular, Angiolite DES offers new long lengths of 44 and 49mm.

iVascular, Angiolite 6.00mm maximum overexpansion capacity.

Angiolite is now reimbursed in Belgium.

iVascular- MERLION Trial 6-month outcomes have been presented at VIVA 2020 Late breaking trial session.

iVascular COVID 19 letter

iVascular – essential pro, new coronary drug coated balloon

ANGIOLITE trial 2 years outcomes have been published at EuroIntervention

About us

Therapeutic areas

- Coronary

- Peripheral

- Neurointerventionism

Clinical Trials

Healthcare Professionals

- PMS: luminor DCB, angiolite DES, peripheral stents,essential - essential pro
- iVascular Grant

Careers

News

Contact

Whistleblower Channel

Coronary

- PMS: luminor DCB, angiolite DES, peripheral stents,essential - essential pro - iVascular Grant

- PMS: luminor DCB, angiolite DES, peripheral stents,essential - essential pro
- iVascular Grant